Prostate Intelligence™

Lucida Medical

Pi, Prostate Intelligence, is an AI and machine learning based software system designed to help radiologists detect and report the presence of prostate cancer lesions from MR scans (MRI). Pi is intended to augment a radiologist’s interpretation of prostate MRI by providing a risk score, prostate segmentation and aiding lesion identification and segmentation.
Product specifications Information source: Vendor
Last updated: June 8, 2021
General
Product name Prostate Intelligence™
Company Lucida Medical
Subspeciality Abdomen
Modality MR
Disease targeted Prostate cancer
Key-features prostate segmentation, AI-supported ROI segmentation, lesion risk score, PI-RADS v2.1 scoring support, structured report
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population Prostate MRI scans with suspicion of prostate cancer
Input MRI, T2, DWI, DCE (optional)
Input format DICOM
Output Segmentation overlay, 3D vizualization, structured report with key images and risk score
Output format DICOM
Technology
Integration Integration in standard reading environment (PACS)
Deployment Locally on dedicated hardware, Cloud-based
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 1 - 10 minutes
Certification
CE
Certified, Class I , MDD
FDA
No or not yet
Market presence
On market since 05-2021
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of analyses, Number of installations
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers